Rosalind Advisors’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABOS
Rosalind Advisors's ABOS Position: Q3 2026 in Review
Rosalind Advisors opened a new position in Acumen Pharmaceuticals (ABOS) in Q3 2026: 1,100,000 shares worth $2.44M. The stake represents 0.78% of the portfolio and ranks #23 among its holdings.
91 funds tracked by Wall St. Rank hold ABOS as of Q3 2026.
- Rosalind Advisors held 1,100,000 shares of Acumen Pharmaceuticals worth $2.44M as of Q3 2026.
- Acumen Pharmaceuticals was a new Rosalind Advisors position in Q3 2026.
- Acumen Pharmaceuticals made up 0.78% of Rosalind Advisors's portfolio in Q3 2026, its #23 holding.
- 91 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q3 2026.
Based on Rosalind Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.